NCT07565805

Brief Summary

Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry (BIOCORE) is a systematic institutional registry on patients undergoing paired CCTA and OCT for validation and development of advanced methods to determine coronary plaque morphology, lesion severity, PCI guidance, and it association with long-term clinical outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
816

participants targeted

Target at P75+ for all trials

Timeline
93mo left

Started Oct 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Oct 2025Dec 2033

Study Start

First participant enrolled

October 17, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 27, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 4, 2026

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2033

Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

3.2 years

First QC Date

April 27, 2026

Last Update Submit

April 27, 2026

Conditions

Keywords

coronary artery diseaseoptical coherence tomographycoronary computed tomography angiography

Outcome Measures

Primary Outcomes (3)

  • Diagnostic accuracy in plaque phenotyping CCTA vs. OCT

    Proportion of correctly classified plaques quantitative computed tomography (QCT) (low-attenuation, non-calcified, calcified plaques) against the gold standard OCT (lipid-rich, fibrous, fibro-calcific plaque)

    Baseline

  • PCI planning with CCTA vs. gold standard OCT

    Diagnostic accuracy of CCTA in identifying the need for PCI and agreement in stent sizing

    Baseline

  • Photon-counting vs. conventional CCTA

    Proportion of correctly classified plaques with photon-counting CCTA vs. conventional CCTA (low-attenuation, non-calcified, calcified plaques) against the gold standard OCT for plaque morphology (lipid-rich, fibrous, fibro-calcific plaque)

    Baseline

Other Outcomes (1)

  • Clinical outcomes throughout 1 and 5 years

    1 and 5 years follow-up

Study Arms (1)

Patients undergoing paired CCTA and OCT

Patients undergoing CCTA and invasive coronary angiography with OCT within 3 months

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing CCTA and invasive coronary angiography with OCT in native coronary vessels within 3 months

You may qualify if:

  • ≥18 years of age
  • Written informed consent
  • CCTA within 3 months from invasive coronary angiography and OCT
  • At least one vessel with ≥50% diameter stenosis on CCTA
  • OCT performed in native coronary arteries (i.e. pre-PCI or no PCI)

You may not qualify if:

  • CCTA performed more than 3 months from OCT
  • Poor OCT quality
  • Poor CCTA quality
  • Coronary anomalies
  • Prior PCI or CABG in the vessel imaged with OCT

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cardiology, Bern University Hospital Inselspital

Bern, 3010, Switzerland

RECRUITING

Related Publications (6)

  • Raber L, Ueki Y, Otsuka T, Losdat S, Haner JD, Lonborg J, Fahrni G, Iglesias JF, van Geuns RJ, Ondracek AS, Radu Juul Jensen MD, Zanchin C, Stortecky S, Spirk D, Siontis GCM, Saleh L, Matter CM, Daemen J, Mach F, Heg D, Windecker S, Engstrom T, Lang IM, Koskinas KC; PACMAN-AMI collaborators. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial. JAMA. 2022 May 10;327(18):1771-1781. doi: 10.1001/jama.2022.5218.

    PMID: 35368058BACKGROUND
  • Bar S, Knuuti J, Saraste A, Nurmohamed NS, Jukema RA, Klen R, Bax JJ, Knaapen P, Danad I, Maaniitty T. Outcomes with revascularization vs. medical therapy according to plaque burden from coronary computed tomography angiography. Eur Heart J Cardiovasc Imaging. 2026 Feb 27;27(3):554-566. doi: 10.1093/ehjci/jeaf372.

    PMID: 41460775BACKGROUND
  • Bar S, Knuuti J, Saraste A, Klen R, Kero T, Nabeta T, Bax JJ, Danad I, Nurmohamed NS, Jukema RA, Knaapen P, Maaniitty T. Derivation and validation of an artificial intelligence-based plaque burden safety cut-off for long-term acute coronary syndrome from coronary computed tomography angiography. Eur Heart J Cardiovasc Imaging. 2025 Jun 30;26(7):1163-1173. doi: 10.1093/ehjci/jeaf121.

    PMID: 40243706BACKGROUND
  • Sandoval Y, Leipsic JA, Collet C, Ali ZA, Azzalini L, Barbato E, Cavalcante JL, Costa RA, Garcia-Garcia HM, Jones DA, Khoo JK, Maran A, Nieman K, Pinilla-Echeverri N, Seto AH, Shlofmitz E, Brilakis ES. Coronary Computed Tomography Angiography to Guide Percutaneous Coronary Intervention: Expert Opinion from a SCAI/SCCT Roundtable. J Soc Cardiovasc Angiogr Interv. 2025 May 1;4(6):103664. doi: 10.1016/j.jscai.2025.103664. eCollection 2025 Jun.

    PMID: 40630246BACKGROUND
  • Williams MC, Kwiecinski J, Doris M, McElhinney P, D'Souza MS, Cadet S, Adamson PD, Moss AJ, Alam S, Hunter A, Shah ASV, Mills NL, Pawade T, Wang C, Weir McCall J, Bonnici-Mallia M, Murrills C, Roditi G, van Beek EJR, Shaw LJ, Nicol ED, Berman DS, Slomka PJ, Newby DE, Dweck MR, Dey D. Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Circulation. 2020 May 5;141(18):1452-1462. doi: 10.1161/CIRCULATIONAHA.119.044720. Epub 2020 Mar 16.

    PMID: 32174130BACKGROUND
  • Nieman K, Garcia-Garcia HM, Hideo-Kajita A, Collet C, Dey D, Pugliese F, Weissman G, Tijssen JGP, Leipsic J, Opolski MP, Ferencik M, Lu MT, Williams MC, Bruining N, Blanco PJ, Maurovich-Horvat P, Achenbach S. Standards for quantitative assessments by coronary computed tomography angiography (CCTA): An expert consensus document of the society of cardiovascular computed tomography (SCCT). J Cardiovasc Comput Tomogr. 2024 Sep-Oct;18(5):429-443. doi: 10.1016/j.jcct.2024.05.232. Epub 2024 Jun 6.

    PMID: 38849237BACKGROUND

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Lorenz Räber, Prof. MD-PhD

    Department of Cardiology, Bern University Hospital Inselspital, Switzerland

    STUDY CHAIR
  • Sarah Bär, MD-PhD

    Department of Cardiology, Bern University Hospital Inselspital, Switzerland

    PRINCIPAL INVESTIGATOR
  • Christoph Gräni, Prof. MD-PhD

    Department of Cardiology, Bern University Hospital Inselspital, Switzerland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sarah Bär, MD, PhD

CONTACT

Räber Lorenz, Prof. MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2026

First Posted

May 4, 2026

Study Start

October 17, 2025

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2033

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Data will be shared upon reasonable request from the principal investigator.

Locations